Soluble urokinase-type plasminogen activator receptor (suPAR) is a risk indicator for eGFR loss in kidney transplant recipients
Abstract The prognostic significance of suPAR in various kidney diseases has recently been demonstrated. Its role in transplantation-specific outcomes is still largely unknown. Therefore, we prospectively investigated the prognostic relevance of suPAR in patients before and one year after kidney tra...
Main Authors: | Ulrich Jehn, Katharina Schütte-Nütgen, Ute Henke, Hermann Pavenstädt, Barbara Suwelack, Stefan Reuter |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2021-02-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-021-83333-7 |
Similar Items
-
Prognostic Value of Growth Differentiation Factor 15 in Kidney Donors and Recipients
by: Ulrich Jehn, et al.
Published: (2020-05-01) -
Kinetics of the soluble urokinase plasminogen activator receptor (suPAR) in cirrhosis.
by: Emilie Garnæs, et al.
Published: (2019-01-01) -
Soluble Urokinase Plasminogen Activator Receptor (suPAR) Concentrations Are Elevated in Patients with Neuroendocrine Malignancies
by: Burcin Özdirik, et al.
Published: (2020-05-01) -
Serum soluble urokinase plasminogen activator receptor (suPAR) in adults with growth hormone deficiency
by: Charlotte Höybye, et al.
Published: (2019-05-01) -
Increased Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR) Levels in Plasma of Suicide Attempters.
by: Filip Ventorp, et al.
Published: (2015-01-01)